Amneal Pharmaceutical is now shipping Bexarotene Gel, 1%, an AB-rated generic equivalent to Targretin®. The Amneal product is sold in a carton containing one 60 gram aluminum tube. The gel is a clear, colorless gelled solution with a homogenous consistency.
Approved on April 27 of this year as an Abbreviated New Drug Application (ANDA) with CGT exclusivity by the US FDA, the Ameal product is the first true generic equivalent for Targretin® currently on the market.
According to IQVIA®, U.S. annual sales for Bexarotene Gel, 1%, for the 12 months ended April 2022 were $21,804,343.
Amneal Bexarotene Gel, 1% is available through wholesalers and distributors as well as directly to the trade.
Click here for full prescribing information.
